Prevalence and Correlates of Bipolar Spectrum Disorder in the World Mental Health Survey Initiative | Global Health | JAMA Psychiatry | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.239.150.57. Please contact the publisher to request reinstatement.
1.
World Health Organization, The World Health Report 2002: Reducing Risks, Promoting Healthy Life.  Geneva, Switzerland World Health Organization2002;
2.
Weissman  MMBland  RCCanino  GJFaravelli  CGreenwald  SHwu  HGJoyce  PRKaram  EGLee  CKLellouch  JLépine  JPNewman  SCRubio-Stipec  MWells  JEWickramaratne  PJWittchen  HYeh  EK Cross-national epidemiology of major depression and bipolar disorder.  JAMA 1996;276 (4) 293- 299PubMedGoogle Scholar
3.
Bauer  MPfennig  A Epidemiology of bipolar disorders.  Epilepsia 2005;46(suppl 4)8- 13PubMedGoogle Scholar
4.
Pini  Sde Queiroz  VPagnin  DPezawas  LAngst  JCassano  GBWittchen  HU Prevalence and burden of bipolar disorders in European countries.  Eur Neuropsychopharmacol 2005;15 (4) 425- 434PubMedGoogle Scholar
5.
Sherazi  RMcKeon  PMcDonough  MDaly  IKennedy  N What's new? the clinical epidemiology of bipolar I disorder.  Harv Rev Psychiatry 2006;14 (6) 273- 284PubMedGoogle Scholar
6.
Waraich  PGoldner  EMSomers  JMHsu  L Prevalence and incidence studies of mood disorders: a systematic review of the literature.  Can J Psychiatry 2004;49 (2) 124- 138PubMedGoogle Scholar
7.
Goodwin  FJamison  K Manic-Depressive Illness. 2nd London, England Oxford University Press2007;
8.
Merikangas  KRPato  M Recent developments in the epidemiology of bipolar disorder in adults and children: magnitude, correlates, and future directions.  Clin Psychol Sci Pract 2009;16 (2) 121- 133doi:10.1111/j.1468-2850.2009.01152.xGoogle Scholar
9.
Gureje  OLasebikan  VOKola  LMakanjuola  VA Lifetime and 12-month prevalence of mental disorders in the Nigerian Survey of Mental Health and Well-Being.  Br J Psychiatry 2006;188465- 471PubMedGoogle Scholar
10.
Grant  BFStinson  FSHasin  DSDawson  DAChou  SPRuan  WJHuang  B Prevalence, correlates, and comorbidity of bipolar I disorder and axis I and II disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions.  J Clin Psychiatry 2005;66 (10) 1205- 1215PubMedGoogle Scholar
11.
Kramer  M Cross-national study of diagnosis of the mental disorders: origin of the problem.  Am J Psychiatry 1969;10(suppl)1- 11PubMedGoogle Scholar
12.
Zubin  J Cross-national study of diagnosis of the mental disorders: methodology and planning.  Am J Psychiatry 1969;10(suppl)12- 20PubMedGoogle Scholar
13.
Cooper  JEKendell  REGurland  BSharpe  LCopeland  JRMSimon  R Psychiatric Diagnosis in New York and London: A Comparative Study of Mental Hospital Admissions.  London, England Oxford University Press1972;
14.
Kessler  RCAbelson  JDemler  OEscobar  JIGibbon  MGuyer  MEHowes  MJJin  RVega  WAWalters  EEWang  PZaslavsky  AZheng  H Clinical calibration of DSM-IV diagnoses in the World Mental Health (WMH) version of the World Health Organization (WHO) Composite International Diagnostic Interview (WMHCIDI).  Int J Methods Psychiatr Res 2004;13 (2) 122- 139PubMedGoogle Scholar
15.
Angst  JGamma  ALewinsohn  P The evolving epidemiology of bipolar disorder.  World Psychiatry 2002;1 (3) 146- 148PubMedGoogle Scholar
16.
Judd  LLAkiskal  HS The prevalence and disability of bipolar spectrum disorders in the US population: re-analysis of the ECA database taking into account subthreshold cases.  J Affect Disord 2003;73 (1-2) 123- 131PubMedGoogle Scholar
17.
Merikangas  KRAkiskal  HSAngst  JGreenberg  PEHirschfeld  RMPetukhova  MKessler  RC Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication.  Arch Gen Psychiatry 2007;64 (5) 543- 552PubMedGoogle Scholar
18.
Zimmermann  PBrückl  TNocon  APfister  HLieb  RWittchen  HUHolsboer  FAngst  J Heterogeneity of DSM-IV major depressive disorder as a consequence of subthreshold bipolarity.  Arch Gen Psychiatry 2009;66 (12) 1341- 1352PubMedGoogle Scholar
19.
Angst  JGamma  ABenazzi  FAjdacic  VEich  DRössler  W Toward a re-definition of subthreshold bipolarity: epidemiology and proposed criteria for bipolar-II, minor bipolar disorders and hypomania.  J Affect Disord 2003;73 (1-2) 133- 146PubMedGoogle Scholar
20.
Angst  J The emerging epidemiology of hypomania and bipolar II disorder.  J Affect Disord 1998;50 (2-3) 143- 151PubMedGoogle Scholar
21.
Kessler  RCAkiskal  HSAngst  JGuyer  MHirschfeld  RMMerikangas  KRStang  PE Validity of the assessment of bipolar spectrum disorders in the WHO CIDI 3.0.  J Affect Disord 2006;96 (3) 259- 269PubMedGoogle Scholar
22.
Wang  PSAngermeyer  MBorges  GBruffaerts  RTat Chiu  Wde Girolamo  GFayyad  JGureje  OHaro  JMHuang  YKessler  RCKovess  VLevinson  DNakane  YOakley Brown  MAOrmel  JHPosada-Villa  JAguilar-Gaxiola  SAlonso  JLee  SHeeringa  SPennell  BEChatterji  SUstün  TB Delay and failure in treatment seeking after first onset of mental disorders in the World Health Organization's World Mental Health Survey Initiative.  World Psychiatry 2007;6 (3) 177- 185PubMedGoogle Scholar
23.
Heeringa  S Sampling designs and sampling procedures. RC  KesslerIn:eds.The WHO World Mental Health Surveys: Global Perspectives on the Epidemiology of Mental Disorders. New York, NY Cambridge University Press2008;14- 32
24.
World Bank, Data and statistics, 2008. http://data.worldbank.org/about/country-classifications/country-and-lending-groupsAccessed September 172008;
25.
Pennell  BE Implementation of the World Mental Health Surveys. RC  KesslerIn:eds.The WHO World Mental Health Surveys: Global Perspectives on the Epidemiology of Mental Disorders. New York, NY Cambridge University Press2008;33- 57
26.
Young  RCBiggs  JTZiegler  VEMeyer  DA A rating scale for mania: reliability, validity and sensitivity.  Br J Psychiatry 1978;133429- 435PubMedGoogle Scholar
27.
Gracious  BLYoungstrom  EAFindling  RLCalabrese  JR Discriminative validity of a parent version of the Young Mania Rating Scale.  J Am Acad Child Adolesc Psychiatry 2002;41 (11) 1350- 1359PubMedGoogle Scholar
28.
Rush  AJTrivedi  MHIbrahim  HMCarmody  TJArnow  BKlein  DNMarkowitz  JCNinan  PTKornstein  SManber  RThase  MEKocsis  JHKeller  MB The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression.  Biol Psychiatry 2003;54 (5) 573- 583PubMedGoogle Scholar
29.
Leon  ACOlfson  MPortera  LFarber  LSheehan  DV Assessing psychiatric impairment in primary care with the Sheehan Disability Scale.  Int J Psychiatry Med 1997;27 (2) 93- 105PubMedGoogle Scholar
30.
First  MSpitzer  RGibbon  MWilliams  J Structured Clinical Interview for DSM-IV Axis I Disorders, Research Version, Non-patient Edition (SCID-I/NP).  New York Biometrics Research Dept, New York State Psychiatric Institute2002;
31.
SAS Institute, Inc, SAS/STAT Software: Changes and Enhancements, Release 8.2.  Cary, NC SAS Publishing2001;
32.
Halli  SRao  KHalli  S Advanced Techniques of Population Analysis.  New York, NY Plenum Press1992;
33.
Wolter  K Introduction to Variance Estimation.  New York, NY Springer-Verlag1985;
34.
Angst  JCui  LSwendsen  JRothen  SCravchik  AKessler  RCMerikangas  KR Major depressive disorder with subthreshold bipolarity in the National Comorbidity Survey Replication.  Am J Psychiatry 2010;167 (10) 1194- 1201PubMedGoogle Scholar
35.
Keller  MB Prevalence and impact of comorbid anxiety and bipolar disorder.  J Clin Psychiatry 2006;67(suppl 1)5- 7PubMedGoogle Scholar
36.
Lewinsohn  PMSeeley  JRBuckley  MEKlein  DN Bipolar disorder in adolescence and young adulthood.  Child Adolesc Psychiatr Clin N Am 2002;11 (3) 461- 475, viiPubMedGoogle Scholar
37.
Duffy  AAlda  MCrawford  LMilin  RGrof  P The early manifestations of bipolar disorder: a longitudinal prospective study of the offspring of bipolar parents.  Bipolar Disord 2007;9 (8) 828- 838PubMedGoogle Scholar
38.
Henin  ABiederman  JMick  ESachs  GSHirshfeld-Becker  DRSiegel  RSMcMurrich  SGrandin  LNierenberg  AA Psychopathology in the offspring of parents with bipolar disorder: a controlled study.  Biol Psychiatry 2005;58 (7) 554- 561PubMedGoogle Scholar
39.
Strakowski  SMDelBello  MP The co-occurrence of bipolar and substance use disorders.  Clin Psychol Rev 2000;20 (2) 191- 206PubMedGoogle Scholar
40.
Merikangas  KRHerrell  RSwendsen  JRössler  WAjdacic-Gross  VAngst  J Specificity of bipolar spectrum conditions in the comorbidity of mood and substance use disorders: results from the Zurich cohort study.  Arch Gen Psychiatry 2008;65 (1) 47- 52PubMedGoogle Scholar
41.
Wittchen  HUMhlig  SPezawas  L Natural course and burden of bipolar disorders.  Int J Neuropsychopharmacol 2003;6 (2) 145- 154PubMedGoogle Scholar
42.
Morgan  VAMitchell  PBJablensky  AV The epidemiology of bipolar disorder: sociodemographic, disability and service utilization data from the Australian National Study of Low Prevalence (Psychotic) Disorders.  Bipolar Disord 2005;7 (4) 326- 337PubMedGoogle Scholar
43.
Tohen  MFrank  EBowden  CLColom  FGhaemi  SNYatham  LNMalhi  GSCalabrese  JRNolen  WAVieta  EKapczinski  FGoodwin  GMSuppes  TSachs  GSChengappa  KRGrunze  HMitchell  PBKanba  SBerk  M The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders.  Bipolar Disord 2009;11 (5) 453- 473PubMedGoogle Scholar
Original Article
March 7, 2011

Prevalence and Correlates of Bipolar Spectrum Disorder in the World Mental Health Survey Initiative

Author Affiliations

Author Affiliations: National Institute of Mental Health, Bethesda, Maryland (Drs Merikangas and He); Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts (Mr Jin, Dr Kessler, and Ms Sampson); Department of Psychiatry; The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong (Dr Lee) and Shenzhen Institute of Mental Health and Shenzhen Kangning Hospital, Shenzhen (Dr Hu), People's Republic of China; Section of Psychiatric Epidemiology (Drs Viana and Andrade) and Laboratory of Medical Investigation 23 (Dr Andrade), Institute of Psychiatry, School of Medicine, University of São Paulo, São Paulo, Brazil; St George Hospital University Medical Center, Balamand University, Faculty of Medicine, Institute for Development, Research, Advocacy and Applied Care, Medical Institute for Neuropsychological Disorders, Beirut, Lebanon (Dr Karam); Department of Psychiatry, University of Medicine and Pharmacy “Carol Davila,” Bucharest, Romania (Dr Ladea); National Institute of Psychiatry, Mexico City, Mexico (Dr Medina-Mora); Health Center, Keio University, Yokohama, Japan (Dr Ono); Colegio Mayor de Cundinamarca University, Bogota, Colombia (Dr Posada-Villa); Department of Psychiatry, All India Institute of Medical Sciences, Delhi, India (Dr Sagar); Christchurch School of Medicine and Health Sciences, Christchurch, New Zealand (Dr Wells); and National Center of Public Health Protection, Directorate Mental Health, Sofia, Bulgaria (Dr Zarkov).

Arch Gen Psychiatry. 2011;68(3):241-251. doi:10.1001/archgenpsychiatry.2011.12
Abstract

Context  There is limited information on the prevalence and correlates of bipolar spectrum disorder in international population-based studies using common methods.

Objectives  To describe the prevalence, impact, patterns of comorbidity, and patterns of service utilization for bipolar spectrum disorder (BPS) in the World Health Organization World Mental Health Survey Initiative.

Design, Setting, and Participants  Cross-sectional, face-to-face, household surveys of 61 392 community adults in 11 countries in the Americas, Europe, and Asia assessed with the World Mental Health version of the World Health Organization Composite International Diagnostic Interview, version 3.0, a fully structured, lay-administered psychiatric diagnostic interview.

Main Outcome Measures  Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition) disorders, severity, and treatment.

Results  The aggregate lifetime prevalences were 0.6% for bipolar type I disorder (BP-I), 0.4% for BP-II, 1.4% for subthreshold BP, and 2.4% for BPS. Twelve-month prevalences were 0.4% for BP-I, 0.3% for BP-II, 0.8% for subthreshold BP, and 1.5% for BPS. Severity of both manic and depressive symptoms as well as suicidal behavior increased monotonically from subthreshold BP to BP-I. By contrast, role impairment was similar across BP subtypes. Symptom severity was greater for depressive episodes than manic episodes, with approximately 74.0% of respondents with depression and 50.9% of respondents with mania reporting severe role impairment. Three-quarters of those with BPS met criteria for at least 1 other disorder, with anxiety disorders (particularly panic attacks) being the most common comorbid condition. Less than half of those with lifetime BPS received mental health treatment, particularly in low-income countries, where only 25.2% reported contact with the mental health system.

Conclusions  Despite cross-site variation in the prevalence rates of BPS, the severity, impact, and patterns of comorbidity were remarkably similar internationally. The uniform increases in clinical correlates, suicidal behavior, and comorbidity across each diagnostic category provide evidence for the validity of the concept of BPS. Treatment needs for BPS are often unmet, particularly in low-income countries.

×